One should note that our global analysis, in common with others to date, was limited by the heterogeneity of substitution rates across tumour types and by the numbers of mutations found within TF binding sites, which bounded the statistical power of our analyses; further, all p-values shown are uncorrected for multiple testing of 118 binding motifs. The gene discussed is TF; the disease is neoplasm.